| Landscape and dynamics of single immune cells in hepatocellular carcinoma Q Zhang, Y He, N Luo, SJ Patel, Y Han, R Gao, M Modak, S Carotta, ... Cell 179 (4), 829-845. e20, 2019 | 1245 | 2019 |
| Identification of essential genes for cancer immunotherapy SJ Patel, NE Sanjana, RJ Kishton, A Eidizadeh, SK Vodnala, M Cam, ... Nature 548 (7669), 537-542, 2017 | 904 | 2017 |
| Ionic immune suppression within the tumour microenvironment limits T cell effector function R Eil, SK Vodnala, D Clever, CA Klebanoff, M Sukumar, JH Pan, ... Nature 537 (7621), 539-543, 2016 | 620 | 2016 |
| T cell stemness and dysfunction in tumors are triggered by a common mechanism SK Vodnala, R Eil, RJ Kishton, M Sukumar, TN Yamamoto, NH Ha, ... Science 363 (6434), eaau0135, 2019 | 478 | 2019 |
| Mitochondrial membrane potential identifies cells with enhanced stemness for cellular therapy M Sukumar, J Liu, GU Mehta, SJ Patel, R Roychoudhuri, JG Crompton, ... Cell metabolism 23 (1), 63-76, 2016 | 383 | 2016 |
| BACH2 regulates CD8+ T cell differentiation by controlling access of AP-1 factors to enhancers R Roychoudhuri, D Clever, P Li, Y Wakabayashi, KM Quinn, CA Klebanoff, ... Nature immunology 17 (7), 851-860, 2016 | 319 | 2016 |
| Memory T cell–driven differentiation of naive cells impairs adoptive immunotherapy CA Klebanoff, CD Scott, AJ Leonardi, TN Yamamoto, AC Cruz, C Ouyang, ... The Journal of clinical investigation 126 (1), 318-334, 2016 | 276 | 2016 |
| Cish actively silences TCR signaling in CD8+ T cells to maintain tumor tolerance DC Palmer, GC Guittard, Z Franco, JG Crompton, RL Eil, SJ Patel, Y Ji, ... Journal of Experimental Medicine 212 (12), 2095-2113, 2015 | 198 | 2015 |
| Multi-phenotype CRISPR-Cas9 screen identifies p38 kinase as a target for adoptive immunotherapies D Gurusamy, AN Henning, TN Yamamoto, Z Yu, N Zacharakis, S Krishna, ... Cancer cell 37 (6), 818-833. e9, 2020 | 148 | 2020 |
| Lineage relationship of CD8+ T cell subsets is revealed by progressive changes in the epigenetic landscape JG Crompton, M Narayanan, S Cuddapah, R Roychoudhuri, Y Ji, W Yang, ... Cellular & molecular immunology 13 (4), 502-513, 2016 | 134 | 2016 |
| A Systems Genetics Approach Identifies CXCL14, ITGAX, and LPCAT2 as Novel Aggressive Prostate Cancer Susceptibility Genes KA Williams, M Lee, Y Hu, J Andreas, SJ Patel, S Zhang, P Chines, ... PLoS genetics 10 (11), e1004809, 2014 | 132 | 2014 |
| The transcription factor BACH2 promotes tumor immunosuppression R Roychoudhuri, RL Eil, D Clever, CA Klebanoff, M Sukumar, FM Grant, ... The Journal of clinical investigation 126 (2), 599-604, 2016 | 59 | 2016 |
| Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade DC Palmer, BR Webber, Y Patel, MJ Johnson, CM Kariya, WS Lahr, ... Med 3 (10), 682-704. e8, 2022 | 58 | 2022 |
| GNL3 and SKA3 are novel prostate cancer metastasis susceptibility genes M Lee, KA Williams, Y Hu, J Andreas, SJ Patel, S Zhang, NPS Crawford Clinical & experimental metastasis 32, 769-782, 2015 | 54 | 2015 |
| Germline genetic variation modulates tumor progression and metastasis in a mouse model of neuroendocrine prostate carcinoma SJ Patel, AA Molinolo, S Gutkind, NPS Crawford PloS one 8 (4), e61848, 2013 | 31 | 2013 |
| Metastasis-associated protein ribosomal RNA processing 1 homolog B (RRP1B) modulates metastasis through regulation of histone methylation M Lee, AM Dworkin, J Lichtenberg, SJ Patel, NS Trivedi, D Gildea, ... Molecular Cancer Research 12 (12), 1818-1828, 2014 | 24 | 2014 |
| 31st annual meeting and associated programs of the society for immunotherapy of cancer (Sitc 2016): Part two: National harbor, md, USA. 9-13 November 2016 C Ager, M Reilley, C Nicholas, T Bartkowiak, A Jaiswal, M Curran, ... Journal for ImmunoTherapy of Cancer 4, 107-221, 2016 | 13 | 2016 |
| 333 Targeting the apical intracellular checkpoint CISH unleashes T cell neoantigen reactivity and effector program D Palmer, B Webber, Y Patel, M Johnson, C Kariya, W Lahr, M Parkhurst, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | 10 | 2020 |
| Cancer genes disfavoring T cell immunity identified via integrated systems approach RJ Kishton, SJ Patel, AE Decker, SK Vodnala, M Cam, TN Yamamoto, ... Cell reports 40 (5), 2022 | 9 | 2022 |
| LAIR-1 agonism as a therapy for acute myeloid leukemia RR Lovewell, J Hong, S Kundu, CM Fielder, Q Hu, KW Kim, HE Ramsey, ... The Journal of Clinical Investigation 133 (22), 2023 | 7 | 2023 |
Nicholas P Restifo, MDCellular Immunotherapy ExplorerZweryfikowany adres z medici.co